# PDUFA Pilot Project: Proprietary Name Review - Concept Paper - FDA Guidance Document

Source: https://www.globalkeysolutions.net/guidances/concept-paper/pdufa-pilot-project-proprietary-name-review-concept-paper/c8f1f3f1-e618-4d0d-9264-921efbd1440f

> FDA guidance document: PDUFA Pilot Project: Proprietary Name Review - Concept Paper. Issue date: October 07, 2008. Get complete insights and analysis.

---

## Details

- Title: PDUFA Pilot Project: Proprietary Name Review - Concept Paper
- Communication Type: Concept Paper
- Product Type: drugs
- Office Name: Center for Drug Evaluation and Research
- Office URL: /offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
- Issue Date: 2008-10-07
- Last Changed: 2020-04-27
- Docket Number: <a href="https://www.regulations.gov/docket/FDA-2008-N-0281">FDA-2008-N-0281</a>

## Related Documents

- [S3A Toxicokinetics: The Assessment of Systemic Exposure in Toxicity Studies](https://www.globalkeysolutions.net/guidances/guidance-document/s3a-toxicokinetics-the-assessment-of-systemic-exposure-in-toxicity-studies/e53cdb09-0178-4fb9-ad0d-f3288ea32cdd)
- [Q5C Quality of Biotechnological Products: Stability Testing of Biotechnological/Biological Products](https://www.globalkeysolutions.net/guidances/guidance-document/q5c-quality-of-biotechnological-products-stability-testing-of-biotechnologicalbiological-products/371b51f2-ae87-4ef8-aa87-6a82dbe5a1eb)
- [Content and Format of Investigational New Drug Applications (INDs) for Phase 1 Studies of Drugs, Including Well-Characterized, Therapeutic, Biotechnology-derived Products:  Guidance for Industry](https://www.globalkeysolutions.net/guidances/guidance-document/content-and-format-of-investigational-new-drug-applications-inds-for-phase-1-studies-of-drugs-including-well-characterized-therapeutic-biotechnology-derived-products-guidance-for-industry/ecc5878c-4062-49df-90cc-6ac91b3adb4c)